Effectiveness Of Psychoeducation And Assertive Training (PEAT) Combined For Improving Medication Adherence In Patients With Schizophrenia
Main Article Content
Abstract
Background: Non-adherence behaviors have a variety of causes, from suffering negative drug side effects to having scepticism regarding the effectiveness of recommended treatments. Recognising these complex relationships is essential to creating strategies that effectively manage the psychosocial as well as medical components of schizophrenia. The purpose of this study is to investigate how a combination of psychoeducation and assertive training can improve medication adherence in people with schizophrenia.
Methods: A pretest-posttest quasi-experiment design was employed in this study as part of a quantitative research technique. Demographics and the Morisky Medication Adherence Questionnaire were used in conjunction with observation to collect data. Based on room-based simple random sampling, 80 patients with schizophrenia who met the inclusion criteria were split into two groups. Of these, 38 patients in the intervention group and 36 responders in the control group finished the study. This study made use of the five-stage Psychoeducation and Assertive Training (PEAT) module.
Results: A combination of psychoeducation and assertiveness training (PEAT) was found to have an effect on medication adherence in this study. Following PEAT, patients with schizophrenia had a mean medication adherence of 5.92±1.29. The statistical test findings showed that the mean medication adherence of schizophrenic patients receiving PEAT differed significantly (p value <0x7E>0.001) from those who did not.
Conclusion: Studies show that putting more of an emphasis on PEAT can help hospitals treat patients with schizophrenia more consistently by helping them take their medications as prescribed. Additionally, patients with schizophrenia should have a treatment plan that includes PEAT.
Article Details
References
Bui, T. N. T., Hotham, E., Loughhead, M., McMillan, S. S., Procter, N., Poole, K., & Suppiah, V. (2022). Exploring mental health clients’ current medication knowledge, beliefs and experience with healthcare providers in the community in South Australia. Health and Social Care in the Community, 30(6), e5968–e5978. https://doi.org/10.1111/hsc.14029
Cho, M., & Jang, S. J. (2019). Effect of an emotion management programme for patients with schizophrenia: A quasi-experimental design. International Journal of Mental Health Nursing, 28(2), 592–604. https://doi.org/10.1111/inm.12565
Ertem, M. Y., & Duman, Z. Ç. (2019). The effect of motivational interviews on treatment adherence and insight levels of patients with schizophrenia: A randomized controlled study. Perspectives in Psychiatric Care, 55(1), 75–86. https://doi.org/10.1111/ppc.12301
Ganesan, S., Selvaraj, N., Dass, V. K., Jayabalan, N., Rajamohammad, M. A., & Anandan, I. (2018). Assessment of drug attitude, medication adherence and quality of life among psychiatric patients in South Indian population: a cross sectional study. International Journal of Basic & Clinical Pharmacology, 8(1), 61. https://doi.org/10.18203/2319-2003.ijbcp20185159
He, H., Hu, C., Ren, Z., Bai, L., Gao, F., & Lyu, J. (2020). Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017. Journal of Psychiatric Research, 125, 96–105. https://doi.org/10.1016/j.jpsychires.2020.03.015
Hsieh, W. L., Yeh, S. T., Liu, W. I., Li, I. H., Lee, S. K., & Chien, W. T. (2022). Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model. Patient Preference and Adherence, 16(March), 1017–1026. https://doi.org/10.2147/PPA.S351848
Kirchner, S. K., Lauseker, M., Adorjan, K., Anderson-Schmidt, H., Anghelescu, I. G., Baune, B. T., Budde, M., Dannlowski, U., Dietrich, D. E., Fallgatter, A. J., Falkai, P., Figge, C., Gade, K., Heilbronner, U., Hiendl, L., Juckel, G., Kalman, J. L., Klöhn-Saghatolislam, F., Konrad, C., … Senner, F. (2022). Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study. Frontiers in Psychiatry, 12(January), 1–10. https://doi.org/10.3389/fpsyt.2021.713060
Ko, Y., & Park, S. (2021). Life after hospital discharge for people with long-term mental disorders in South Korea: Focusing on the “revolving door phenomenon.” Perspectives in Psychiatric Care, 57(2), 531–538. https://doi.org/10.1111/ppc.12575
Mehralian, G., Sharif, Z., & Abbasian, G. (2019). Medication adherence in patients with psychiatric disorders in Tehran. Journal of Pharmaceutical Health Services Research, 10(3), 347–352. https://doi.org/10.1111/jphs.12312
Nyanyiwa, S., Peters, K., & Murphy, G. (2022). A scoping review: Treatment attitudes and adherence for adults with schizophrenia. Journal of Clinical Nursing, August 2021, 1–16. https://doi.org/10.1111/jocn.16219
Paukkonen, L., Oikarinen, A., Kähkönen, O., & Kyngäs, H. (2021). Adherence to self-management in patients with multimorbidity and associated factors: A cross-sectional study in primary health care. Journal of Clinical Nursing, October, 1–16. https://doi.org/10.1111/jocn.16099
Şahin Altun, Ö., Özer, D., Bulut, R., & Şahin, F. (2021). Investigation of the relationship between the negative automatic thoughts of patients with schizophrenia and their levels of social functionality. Perspectives in Psychiatric Care, November 2021, 1819–1825. https://doi.org/10.1111/ppc.12994
Suen, Y. N., Yeung, E. T. W., Chan, S. K. W., Hui, C. L. M., Lee, E. H. M., Chang, W. C., Chan, C. Y. H., & Chen, C. E. Y. H. (2021). Integration of biological and psychological illness attributional belief in association with medication adherence behaviour: A path analysis. Early Intervention in Psychiatry, 15(6), 1686–1695. https://doi.org/10.1111/eip.13114
Yildirim, T., & Kavak Budak, F. (2020). The relationship between internalized stigma and loneliness in patients with schizophrenia. Perspectives in Psychiatric Care, 56(1), 168–174. https://doi.org/10.1111/ppc.12399
Yoshimura, B., Sakamoto, S., Sato, K., Takaki, M., & Yamada, N. (2019). Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study. Early Intervention in Psychiatry, 13(3), 589–597. https://doi.org/10.1111/eip.12531
Yu, W., Tong, J., Sun, X., Chen, F., Zhang, J., Pei, Y., Zhang, T., Zhang, J., & Zhu, B. (2021). Analysis of medication adherence and its influencing factors in patients with schizophrenia in the chinese institutional environment. International Journal of Environmental Research and Public Health, 18(9), 1–11. https://doi.org/10.3390/ijerph18094746